Publications by authors named "Maria Michelagnoli"


Skeletal staging in Langerhans cell histiocytosis: a multimodality imaging review.

Skeletal Radiol 2020 Nov 20. Epub 2020 Nov 20.

Department of Radiology, Royal National Orthopaedic Hospital, Brockley Hill, Stanmore, HA7 4LP, UK.

View Article and Find Full Text PDF
November 2020

Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial.

J Clin Oncol 2015 Jul 1;33(20):2279-87. Epub 2015 Jun 1.

Stefan S. Bielack, Klinikum Stuttgart-Olgahospital, Stuttgart; Mathias Werner, Helios Klinikum Emil von Behring; Per-Ulf Tunn, Helios Klinikum Berlin-Buch, Berlin; Knut Helmke, Altonaer Kinderkrankenhaus, Hamburg; Heribert Jürgens, Gabriele Calaminus, Joachim Gerss, and Trude Butterfass-Bahloul, Universitätsklinikum Münster, Münster; Peter Reichardt, Klinik für Interdisziplinäre Onkologie, Bad Saarow, Germany; Sigbjørn Smeland and Kirsten Sundby Hall, Oslo University Hospital; Kirsten Sundby Hall, Norwegian Radium Hospital, Oslo, Norway; Jeremy S. Whelan, University College London Hospitals; Gordana Jovic, Jane M. Hook, and Matthew R. Sydes, University College London; Beatrice Seddon and Maria Michelagnoli, University College Hospital, London; Bernadette Brennan, Christie Hospital and Royal Manchester Children's Hospital, Manchester; Susan Picton, Leeds University Hospital, Leeds, United Kingdom; Neyssa Marina, Stanford University Medical Center; Claudia Deffenbaugh, Lucille Salter Packard Children's Hospital, Palo Alto; Mark D. Krailo, Children's Oncology Group, Arcadia, CA; Mark Gebhardt and Allen Goorin, Dana-Farber Cancer Institute; Mark Gebhardt and Lisa A. Teot, Children's Hospital Boston, Boston, MA; Zsuzsanna Pápai, National Medical Center, Budapest, Hungary; James Meyer, Children's Hospital of Philadelphia and University of Pennsylvania School of Medicine, Philadelphia, PA; Helen Nadel, British Columbia Children's Hospital and University of British Columbia, Vancouver, British Columbia; Mark Bernstein, Dalhousie University, Halifax, Nova Scotia, Canada; R. Lor Randall, University of Utah, Salt Lake City, UT; Rajaram Nagarajan, Cincinnati Children's Hospital Medical Center, Cincinnati, OH; G. Douglas Letson, H. Lee Moffit Cancer Center and Research Institute, Tampa, FL; Daniel Baumhoer, Universitätsspital Basel; Thomas Kühne, University Children's Hospital Basel, Basel, Switzerland; Leo Kager, St Anna's Children Hospital; Reinhard Windhager, Medica

View Article and Find Full Text PDF
July 2015

Screening for Distress in Young People After Treatment for Sarcoma: A Feasibility Study.

J Pediatr Oncol Nurs 2016 Jan-Feb;33(1):25-32. Epub 2015 Feb 2.

Consultant Clinical Psychologist, University College Hospital, London, UK.

View Article and Find Full Text PDF
September 2016

The importance of patient reported functional outcome in paediatric desmoid fibromatosis.

Rare Tumors 2012 Jun 14;4(3):e38. Epub 2012 Aug 14.

Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Nuffield Orthopaedic Hospital, Oxford;

View Article and Find Full Text PDF
June 2012

Interval compressed vincristine, doxorubicin, cyclophosphamide alternating with ifosfamide, etoposide in patients with advanced Ewing's and other Small Round Cell Sarcomas.

Clin Sarcoma Res 2012 Sep 21;2(1):12. Epub 2012 Sep 21.

Department of Oncology, The London Sarcoma Service, University College Hospital London NHS Foundation Trust, 1st Floor Central, 250 Euston Road, London NW1 2PG, UK.

View Article and Find Full Text PDF
September 2012

Improving Outcomes After Relapse in Ewing's Sarcoma: Analysis of 114 Patients From a Single Institution.

Sarcoma 2006 6;2006:83548. Epub 2006 Nov 6.

Department of Oncology, University College Hospital, 250 Euston Road, London NW1 2PG, UK.

View Article and Find Full Text PDF
July 2011

A phase I/II study of doxorubicin, ifosfamide, etoposide and interval methotrexate in patients with poor prognosis osteosarcoma.

Pediatr Blood Cancer 2006 Mar;46(3):345-50

Meyerstein Institute of Oncology, Middlesex Hospital, UCL Hospitals NHS Trust, London, United Kingdom.

View Article and Find Full Text PDF
March 2006

Adolescent oncology--a homeland for the "lost tribe".

Eur J Cancer 2003 Dec;39(18):2571-2

The Middlesex Hospital, London, UK.

View Article and Find Full Text PDF
December 2003

Myogenin--a more specific target for RT-PCR detection of rhabdomyosarcoma than MyoD1.

Med Pediatr Oncol 2003 Jan;40(1):1-8

Candlelighter's Children's Cancer Research Laboratory, St. James's University Hospital, Leeds, United Kingdom.

View Article and Find Full Text PDF
January 2003